WaveForm Diabetes Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
102
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$43.2M
WaveForm Diabetes General Information
Description
Developer of diabetes care products intended to monitor blood glucose. The company's products utilize dynamic electrochemistry to extract a spectrum of information inaccessible in traditional static electrochemical methods resulting in consistently achieving good accuracy against a laboratory standard, enabling patients to improve the management of blood glucose levels.
Contact Information
Website
www.waveformdiabetes.comCorporate Office
- 27700 South West 95th Avenue
- Suite 100
- Wilsonville, OR
- United States
Corporate Office
- 27700 South West 95th Avenue
- Suite 100
- Wilsonville, OR
- United States
WaveForm Diabetes Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Merger/Acquisition | 30-Jan-2024 | $43.2M | Completed | Generating Revenue | ||
| 13. Merger/Acquisition | 01-Jun-2023 | Completed | Generating Revenue | |||
| 12. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 11. Later Stage VC | 02-Feb-2022 | Completed | Generating Revenue | |||
| 10. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 03-Jul-2019 | Completed | Generating Revenue | |||
| 8. Debt - General | 29-Sep-2017 | Completed | Generating Revenue | |||
| 7. Debt - General | 06-Feb-2015 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 15-Nov-2007 | $23.7M | $41.3M | Completed | Generating Revenue | |
| 5. Later Stage VC (Series B) | 30-Apr-2007 | $4.91M | $17.6M | Completed | Generating Revenue |
WaveForm Diabetes Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 21,179,370 | $0.010000 | 8% | $0.21 | $0.41 | 2x | $0.21 | 35.53% |
WaveForm Diabetes Comparisons
Industry
Financing
Details
WaveForm Diabetes Competitors (6)
One of WaveForm Diabetes’s 6 competitors is Bigfoot Biomedical, a Formerly VC-backed company based in Milpitas, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bigfoot Biomedical | Formerly VC-backed | Milpitas, CA | ||||
| GlySens | Venture Capital-Backed | San Diego, CA | ||||
| Microlife | Private Equity-Backed | Taipei, Taiwan | ||||
| DexCom | Formerly VC-backed | San Diego, CA | ||||
| Ascensia Diabetes Care | Formerly PE-Backed | Basel, Switzerland |
WaveForm Diabetes Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
WaveForm Diabetes Patents
WaveForm Diabetes Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3165705-A1 | Adjunct data to improve the performance of a continuous glucose monitoring system | Pending | 23-Jan-2020 | ||
| US-20210228114-A1 | Adjunct data to improve the performance of a continuous glucose monitoring system | Pending | 23-Jan-2020 | ||
| WO-2021151002-A1 | Adjunct data to improve the performance of a continuous glucose monitoring system | Inactive | 23-Jan-2020 | ||
| US-12343176-B2 | Sensor signal processing with kalman-based calibration | Active | 04-Jun-2019 | ||
| US-20200383643-A1 | Sensor signal processing with kalman-based calibration | Inactive | 04-Jun-2019 | G16H40/40 |
WaveForm Diabetes Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
WaveForm Diabetes Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Collaborative Seed & Growth Partners | Venture Capital | Minority | ||
| Ferrer Freeman & Company | PE/Buyout | Minority | ||
| Angel (individual) | Minority | |||
| Notable International | Corporation | Minority |
WaveForm Diabetes Acquisitions (1)
WaveForm Diabetes’s most recent deal was a Merger/Acquisition with iSense CGM.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| iSense CGM | Merger/Acquisition | Monitoring Equipment |
WaveForm Diabetes FAQs
-
When was WaveForm Diabetes founded?
WaveForm Diabetes was founded in 2001.
-
Where is WaveForm Diabetes headquartered?
WaveForm Diabetes is headquartered in Wilsonville, OR.
-
What is the size of WaveForm Diabetes?
WaveForm Diabetes has 102 total employees.
-
What industry is WaveForm Diabetes in?
WaveForm Diabetes’s primary industry is Monitoring Equipment.
-
Is WaveForm Diabetes a private or public company?
WaveForm Diabetes is a Private company.
-
What is the current valuation of WaveForm Diabetes?
The current valuation of WaveForm Diabetes is .
-
What is WaveForm Diabetes’s current revenue?
The current revenue for WaveForm Diabetes is .
-
How much funding has WaveForm Diabetes raised over time?
WaveForm Diabetes has raised $159M.
-
Who are WaveForm Diabetes’s investors?
, Collaborative Seed & Growth Partners, Ferrer Freeman & Company, , and Notable International are 5 of 10 investors who have invested in WaveForm Diabetes.
-
Who are WaveForm Diabetes’s competitors?
Bigfoot Biomedical, GlySens, Microlife, DexCom, and Ascensia Diabetes Care are some of the 6 competitors of WaveForm Diabetes.
-
When was WaveForm Diabetes acquired?
WaveForm Diabetes was acquired on 30-Jan-2024.
-
Who acquired WaveForm Diabetes?
WaveForm Diabetes was acquired by Trinity Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
